REPROCELL Wins MSCRF Award to Advance Hypoimmune iPSC Platforms
What happens when cell therapy needs to reach more patients, but manufacturing and immune compatibility still act like locked gates? That is the tension behind REPROCELL’s new Commercialization Award from the Maryland Stem Cell Research Fund, which will support work on hypoimmune iPSC platforms for clinical applications.1 This is not a flashy promise about a […]
NOVAKnee Program Names Made Scientific as Manufacturer for Living Biologic Knee Replacement
Made Scientific will manufacture Columbia’s NOVAKnee implants for a Phase 1 trial expected in 2028 under FDA oversight.
Cellular Intelligence Secures Novo Nordisk Parkinson’s Cell Therapy Rights
What happens when a clinical-stage Parkinson’s cell therapy program changes hands? What should patients, families, and the regenerative medicine field watch next? Cellular Intelligence announced that it has acquired global rights to Novo Nordisk’s clinical-stage cell therapy program for Parkinson’s disease.1 The agreement places a first-in-human Phase 1/2 program under an AI-native TechBio company that […]
Stem Cell Therapy in Florida: A Guide to the New 2026 Landscape
Florida has become a focal point in the regenerative medicine world. A new law has changed the rules for patients seeking stem cell therapy in the state. If you are exploring your options for healing, understanding this new landscape is crucial. Let’s break down what has changed and what it means for you. Florida’s New […]
FDA Grants Clearance for Groundbreaking iPSC-Derived Stem Cell Therapy for Epilepsy
On March 12, 2026, a significant step was taken in the fight against epilepsy. The U.S. Food and Drug Administration (FDA) granted Investigational New Drug (IND) clearance to Unixell Biotech for its innovative cell therapy, UX-GIP001, designed to treat focal epilepsy. This clearance is a major milestone. It marks UX-GIP001 as the first therapy of […]
Is a Cure for Chronic Back Pain on the Horizon?
Millions of people suffer from chronic lower back pain, a condition that can be debilitating and frustrating. For many, current treatments offer little relief, leaving them searching for a better solution. A recent announcement from BioRestorative Therapies brings a new sense of optimism to this search. Landmark Trial Offers Hope BioRestorative Therapies has successfully completed […]
Brain Cell Implants: A New Hope for Parkinson’s Patients?
A groundbreaking clinical trial is testing whether stem cell implants can restore brain function in people with Parkinson’s disease, offering a potential new path to slow the disease and improve quality of life. For the more than one million people in the United States living with Parkinson’s disease, treatment options have been limited to managing […]
CIRM’s $100M Plan to Revolutionize Rare Disease Treatment
For the 30 million Americans living with a rare disease, hope can feel distant. A staggering 95% of these conditions have no approved therapy, leaving patients and their families with few options. But what if we could change that? The California Institute for Regenerative Medicine (CIRM) has announced a groundbreaking $100 million plan to accelerate […]
Is the Future of Gene Editing Finally Here?
Developing new cell therapies is a long and difficult process. Scientists face many challenges, including the precision and safety of gene editing tools. What if there was a faster, more reliable way to bring these treatments to patients? REPROCELL’s latest announcement may have the answer. On January 28, 2026, REPROCELL launched StemEdit, a new clinical […]
New Hope for Long COVID Sufferers: FDA Clears StemCyte’s Cord Blood Therapy for Expanded Access
Are you one of the millions struggling with the lingering effects of Long COVID? Do you feel like you’ve tried everything with no relief? A groundbreaking development from StemCyte offers a new ray of hope. The U.S. Food and Drug Administration (FDA) has just cleared an Expanded Access Program for RegeneCyte®, a cord blood-derived stem […]